<div>Braylynn was born on Saturday April 8th and was diagnosed with NKH on April 17th, 2023. With Braylynns diagnosis comes plenty of obstacles. Plenty of hospital stays and doctors appointments. So many medications, some of which insurance refuses to cover. Battles with insurance to get medications on time. The battles of trying to get ahold of all of her doctors or specialists at a moments notice when something seems wrong. The many, many therapy sessions that she works so hard at. The adaptive devices she NEEDS her in everyday day life that insurance won’t cover because they say “she doesn’t need it”. The seizures daily, the developmental delays, the low muscle tone. This may not be normal to most, but it is our new “normal”. This diagnosis has been one of the hardest things we have ever had to go through but we keep pushing. we keep fighting for our girl. No one should ever have to be told that their baby only has a short time to live. The thought of possibly losing her at or before age 3 is heartbreaking. A child should never be given a life expectancy.
</div>
<div><br />
</div>
<div>This disorder will KILL our babies and the only way we can stop it, is through better treatments and eventually, gene therapy. But due to lack of funds, we aren’t able to receive such treatment. Without the help of the Pharmaceutical companies, the families and friends of those affected by NKH are the ones putting forth the money. Please consider making a donation towards NKH research to SAVE THE LIFE of my beautiful girl Braylynn, and all of the other kids like her.
</div>
<div><br />
</div>
<div>NKH, or Nonketotic Hyperglycinemia, is a very rare, very horrible and very deadly genetic disorder that affects the brain and nervous system. It is a devastating condition that can have lifelong effects on those who are affected by it, and especially on our children. As a caregiver, family member, or loved one of someone with NKH, the impact of this condition can be overwhelming and heartbreaking. This disorder has taken so many CHILDREN from their families and you can never predict when things will happen, what your baby can or can’t do, and how their life will be.
</div>
<div><br />
</div>
<div>Each new day is never promised for her, so we will make sure to create the best life possible for Braylynn. To make memories and give her the experiences of a lifetime.
</div>
<div><br />
</div>
<div>If anyone has questions please feel free to reach out to me, shawn, my mom or my dad and we will answer them to the best of our abilities. Please join us in the fight against the horrible disorder called NKH. You can follow Braylynns journey on [email redacted]tle.with.nkh or our facebook pages: my personal: Caitlin Flinders or our fundraising page: @Braylynnsbucksforbees
</div>
<div><br />
</div>
<div>Please help me save Braylynn and all other NKH kids like her. This is the only way.
</div>
<div><br />
</div>
<div>anything amount will help!
</div>
<div><br />
</div>
<div>we are just so grateful for all of you and your continued support.
</div>
<div><br />
</div>
<div>❤️/Caitlin, Braylynn and Family
</div>

Joan Tuttle

Denice Anderson

Dana Reid

Anonymous

Arlene Clements

Jason Weaver

Shashi Karrennagari

Rakesh Pallagani

Dmitry Panov

Yugadeep bandaru

Sai Lohith Roy Lohith Roy Valleri

Sharon Kitzman

Bianca Moureau

Tom Gilbert

Perryn Holtrop

Team Braylynn and our fight against NKH

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Team Braylynn and our fight against NKH

Still $8,466 to go. Help us build momentum.